CN102337282A - 一种溶栓蛋白酶基因nks1及用途 - Google Patents
一种溶栓蛋白酶基因nks1及用途 Download PDFInfo
- Publication number
- CN102337282A CN102337282A CN2011101359075A CN201110135907A CN102337282A CN 102337282 A CN102337282 A CN 102337282A CN 2011101359075 A CN2011101359075 A CN 2011101359075A CN 201110135907 A CN201110135907 A CN 201110135907A CN 102337282 A CN102337282 A CN 102337282A
- Authority
- CN
- China
- Prior art keywords
- gene
- nks1
- nattokinase
- dna
- reorganization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002537 thrombolytic effect Effects 0.000 title abstract description 5
- 108091005804 Peptidases Proteins 0.000 title abstract 4
- 108010073682 nattokinase Proteins 0.000 claims abstract description 70
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 51
- 230000000694 effects Effects 0.000 claims abstract description 18
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 24
- 239000002773 nucleotide Substances 0.000 claims description 17
- 125000003729 nucleotide group Chemical group 0.000 claims description 17
- 230000008521 reorganization Effects 0.000 claims description 17
- 239000003527 fibrinolytic agent Substances 0.000 claims description 12
- 239000012634 fragment Substances 0.000 claims description 12
- 244000063299 Bacillus subtilis Species 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 9
- 108010073975 Brinolase Proteins 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 150000007523 nucleic acids Chemical class 0.000 claims description 8
- 239000013612 plasmid Substances 0.000 claims description 8
- 238000005215 recombination Methods 0.000 claims description 8
- 230000006798 recombination Effects 0.000 claims description 8
- 230000009257 reactivity Effects 0.000 claims description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims description 4
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 238000013467 fragmentation Methods 0.000 claims description 4
- 238000006062 fragmentation reaction Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000012882 sequential analysis Methods 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 101150028074 2 gene Proteins 0.000 claims description 2
- 238000007622 bioinformatic analysis Methods 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims description 2
- 108091008146 restriction endonucleases Proteins 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 11
- 229940086319 nattokinase Drugs 0.000 abstract description 9
- 239000004365 Protease Substances 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 description 24
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 10
- 235000013557 nattō Nutrition 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 230000003480 fibrinolytic effect Effects 0.000 description 7
- 208000007536 Thrombosis Diseases 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 229940000489 arsenate Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940012957 plasmin Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101359075A CN102337282A (zh) | 2011-05-25 | 2011-05-25 | 一种溶栓蛋白酶基因nks1及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101359075A CN102337282A (zh) | 2011-05-25 | 2011-05-25 | 一种溶栓蛋白酶基因nks1及用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102337282A true CN102337282A (zh) | 2012-02-01 |
Family
ID=45513233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101359075A Pending CN102337282A (zh) | 2011-05-25 | 2011-05-25 | 一种溶栓蛋白酶基因nks1及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102337282A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103589706A (zh) * | 2013-04-25 | 2014-02-19 | 珠海市御品堂生物科技有限公司 | 纳豆激酶的提纯方法及制备方法 |
CN107937374A (zh) * | 2017-12-19 | 2018-04-20 | 江南大学 | 一种热稳定性提高的纳豆激酶 |
-
2011
- 2011-05-25 CN CN2011101359075A patent/CN102337282A/zh active Pending
Non-Patent Citations (4)
Title |
---|
FAN,J.: "ABM97611", 《GENBANK》 * |
FAN,J.: "EF208028", 《GENBANK》 * |
俞路 等: "DNA改组(DNA shufling)及其研究进展", 《生物学杂志》 * |
许钦坤 等: "蛋白质定向进化的研究进展及其应用前景", 《生物技术通讯》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103589706A (zh) * | 2013-04-25 | 2014-02-19 | 珠海市御品堂生物科技有限公司 | 纳豆激酶的提纯方法及制备方法 |
CN103589706B (zh) * | 2013-04-25 | 2016-03-30 | 珠海市御品堂生物科技有限公司 | 纳豆激酶的提纯方法及制备方法 |
CN107937374A (zh) * | 2017-12-19 | 2018-04-20 | 江南大学 | 一种热稳定性提高的纳豆激酶 |
CN107937374B (zh) * | 2017-12-19 | 2020-03-06 | 江南大学 | 一种热稳定性提高的纳豆激酶 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Altaf et al. | Role of fibrinolytic enzymes in anti-thrombosis therapy | |
Choi et al. | Purification and characterization of a novel fibrinolytic enzyme from fruiting bodies of Korean Cordyceps militaris | |
Wei et al. | Strain screening, fermentation, separation, and encapsulation for production of nattokinase functional food | |
WO2022134236A1 (zh) | 一种碱性蛋白酶突变体及其基因、工程菌、制备方法和应用 | |
CN106939315B (zh) | 一种草酸脱羧酶的制备方法及应用 | |
Sheng et al. | Microbial nattokinase: from synthesis to potential application | |
CN102994601A (zh) | 一种利用海洋胶原蛋白酶mcp-01制备胶原蛋白小肽的方法 | |
CN102337282A (zh) | 一种溶栓蛋白酶基因nks1及用途 | |
CN102757973B (zh) | 一种具有溶栓活性的海蚯蚓纤溶酶的cDNA序列及其氨基酸序列 | |
EA038578B1 (ru) | Препарат цистеиновой протеиназы пшеницы тритикаина-альфа, полученной в растворимой форме, и способ получения препарата | |
CN109679941B (zh) | 一种蛹虫草纤维蛋白溶解酶及其制备方法和应用 | |
CN102660565A (zh) | 尖吻蝮蛇血凝酶基因及其表达载体、宿主细胞和重组蛋白的制备方法 | |
CN102021160B (zh) | 一种蛇毒丝氨酸蛋白酶、其编码基因及应用 | |
US8017750B2 (en) | Haemocoagulase | |
CN101705240B (zh) | 巴曲酶基因的合成及其表达产物的制备方法 | |
Kotb | Microbial fibrinolytic enzyme production and applications | |
CN107254452A (zh) | 一种微生物源抗氧化蛋白酶的制备和应用 | |
CN103172730B (zh) | 黑眶蟾蜍胱抑素及其基因和应用 | |
CN100575492C (zh) | 一种编码双齿围沙蚕蛋白酶的cDNA序列及其氨基酸序列 | |
Jiang et al. | Purification and characterization of a novel fibrinolytic enzyme from Whitmania pigra Whitman | |
CN112852788A (zh) | 一种碱性底物选择性提高的枯草蛋白酶e突变体及其应用 | |
KR0180103B1 (ko) | 바실러스 서브틸리스 속 균주 유래의 혈전용해효소 | |
KR101223062B1 (ko) | 재조합 대장균 mk―15을 이용한 혈전용해효소의 대량생산방법 | |
CN101397567A (zh) | 一种新的重组蛇毒金属蛋白酶的表达、复性及其生物学活性 | |
Etienne et al. | New Phylogenetic Molecular Markers in Bacteria of the Genus Bacillus: Fibrinolytic Proteases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: XIA TAO Effective date: 20130620 Owner name: NANJING BIOGEM BIOSCIENCE CO., LTD. Free format text: FORMER OWNER: WANG QIN Effective date: 20130620 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200086 HONGKOU, SHANGHAI TO: 210000 NANJING, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130620 Address after: 210000, Room 301, 302 Hanzhoung Avenue, Gulou District, Jiangsu, Nanjing Applicant after: NANJING BIOGEM BIOSCIENCE CO., LTD. Address before: 200086 Building No. 188, Tongzhou Road, Hongkou District, Shanghai, 3 Applicant before: Wang Qin Applicant before: Xia Tao |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120201 |